Successful cholecalciferol desensitisation in a case of delayed hypersensitivity
Asia Pacific Allergy
; (4): e14-2019.
Article
in En
| WPRIM
| ID: wpr-750179
Responsible library:
WPRO
ABSTRACT
Hypersensitivity to cholecalciferol (vitamin D3) or its active metabolite, calcitriol, is an exceedingly rare clinical phenomenon, with only 2 previously reported cases of suspected immediate hypersensitivity. Diagnosis of delayed drug hypersensitivity reactions is inherently difficult due to the lack of any robust in vitro diagnostic assay, particularly in those patients for whom provocation testing confers an unacceptable risk. In these situations, diagnosis relies on reproducible clinical manifestations following administration of the culprit agent, resolution upon its withdrawal and exclusion of other potential differential diagnoses. Based on these criteria, we propose the first reported case of delayed hypersensitivity to cholecalciferol successfully managed with a desensitisation protocol to pure cholecalciferol.
Key words
Full text:
1
Index:
WPRIM
Main subject:
In Vitro Techniques
/
Calcitriol
/
Cholecalciferol
/
Diagnosis
/
Diagnosis, Differential
/
Drug Hypersensitivity
/
Hypersensitivity
/
Hypersensitivity, Delayed
/
Hypersensitivity, Immediate
Type of study:
Diagnostic_studies
/
Guideline
Limits:
Humans
Language:
En
Journal:
Asia Pacific Allergy
Year:
2019
Type:
Article